Xintela AB Stock: price and insider trades · Sweden

Xintela AB, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finansinspektionen. From 18 October 2025 to 18 October 2026, the disclosure feed for Xintela AB logged 7 filings by 4 insiders.

Not one open-market sale was filed. On the buying side, 3 insiders reported 5 purchases totalling €22k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The buyers include 2 finance chiefs and 1 board member. At €14k, the purchase published on 8 December 2025 by Derek Batcheller is the largest of the period (0.094% of market cap).

Within a 30-day window, 1 purchase overlapped with buying by a second insider. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The most recent open-market purchase was published on 25 September 2026, 22 days ago. The median gap between a trade and its publication by Finansinspektionen is 1 day. The regulation allows three business days to notify a trade (MAR article 19).

For context, the typical company on the same exchange (median of 890 companies) published 7 filings over the same period, against 7 filings here. The full history, which starts in 2025, counts 5 purchases against no sales.

In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.